BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38178954)

  • 1. Clinical characteristics and treatment outcomes of germ cell tumor in Jordan: A tertiary center experience.
    El-Achkar A; Alasadi H; El-Asmar J; Armache A; Abu-Hijlih R; Abu-Hijle F; Al-Ibraheem A; Khzouz J; Salah S; Shahait M
    Arab J Urol; 2023; 21(4):233-239. PubMed ID: 38178954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
    Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
    Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countries.
    Saju SV; Radhakrishnan V; Ganesan TS; Dhanushkodi M; Raja A; Selvaluxmy G; Sagar TG
    Med Oncol; 2019 Feb; 36(3):28. PubMed ID: 30725328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testicular germ cell tumors in patients with human immunodeficiency virus infection.
    Hentrich MU; Brack NG; Schmid P; Schuster T; Clemm C; Hartenstein RC
    Cancer; 1996 May; 77(10):2109-16. PubMed ID: 8640678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
    Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
    Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
    Géczi L; Gomez F; Bak M; Bodrogi I
    J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When is a Seminoma not a Seminoma? The Incidence, Risk Factors and Management of Patients With Testicular Seminoma With Discordant Elevated Serum Alpha-fetoprotein.
    Fero KE; Lec PM; Sharma V; Lenis AT; Low J; Litwin MS; Leapman MS; Chamie K
    Urology; 2021 Nov; 157():188-196. PubMed ID: 34389428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections.
    Spratt DE; Suresh K; Osawa T; Schipper M; Jackson WC; Abugharib A; Lebastchi A; Smith D; Montgomery JS; Palapattu GS; Priya Kunju L; Wu A; Lew M; Tomlins SA; Chinnaiyan AM; Weizer AZ; Hafez KS; Kaffenberger SD; Udager A; Mehra R
    Med Oncol; 2018 Jan; 35(3):21. PubMed ID: 29387987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515).
    Bastos DA; Gongora ABL; Dzik C; Jardim DL; Piva M; Carcano FM; Bertollo G; Trindade K; Fontes MS; Soares A; Reinert T; De Cassia Costamilan R; Villarroel RU; Watarai G; Gazola AA; Preto DDA; Mutti H; Bonalumi Dos Santos M; Mariano RC; Binotto M; Carvalho MM; Oliveira VPDC; Gomes R; Rebelatto TF; Schutz FA; Smaletz O; Fay AP
    Clin Genitourin Cancer; 2023 Jun; 21(3):e104-e113. PubMed ID: 36509612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testicular tumors in children.
    Ciftci AO; Bingöl-Koloğlu M; Senocak ME; Tanyel FC; Büyükpamukçu M; Büyükpamukçu N
    J Pediatr Surg; 2001 Dec; 36(12):1796-801. PubMed ID: 11733909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.
    Balzer BL; Ulbright TM
    Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors.
    Gariscsak PJ; Anson-Cartwright L; Atenafu EG; Jiang DM; Chung P; Bedard P; Warde P; O'Malley M; Sweet J; Glicksman RM; Hamilton RJ
    Eur Urol Open Sci; 2022 Jun; 40():46-53. PubMed ID: 35638085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
    Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
    Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance study for clinical stage I testicular seminomas and nonseminomatous germ cell tumors.
    Suzuki K; Orikasa S; Hoshi S; Yoshikawa K; Imai Y; Aizawa M; Nishimura Y; Okada Y; Ohnuma T; Ogata Y
    Int J Urol; 1998 Nov; 5(6):568-74. PubMed ID: 9855126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncological Outcomes in Japanese Men Undergoing Orchiectomy for Stage I Testicular Germ Cell Tumor.
    Harada K; Miyake H; Ogawa T; Inoue TA; Fujisawa M
    Curr Urol; 2015 Jul; 8(2):84-90. PubMed ID: 26889123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group.
    Aparicio J; Sánchez-Muñoz A; Ochenduszko S; Gumà J; Fernández-Aramburo A; García Del Muro X; Quiroga V; Sastre J; Alonso-Gordoa T; Sagastibelza N; Maroto P; Gómez de Liaño A; Vázquez S; Diz P; Durán I; Domenech M; Pinto A; Hernández A; González-Billalabeitia E; Terrasa J
    J Urol; 2019 Oct; 202(4):742-747. PubMed ID: 31163007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of late relapse on surveillance in patients presenting with clinical stage I testicular cancer.
    Rice KR; Beck SD; Pedrosa JA; Masterson TA; Einhorn LH; Foster RS
    Urology; 2014 Oct; 84(4):886-90. PubMed ID: 25260450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
    Dash A; Carver BS; Stasi J; Bajorin DF; Motzer RJ; Bosl GJ; Sheinfeld J
    Cancer; 2008 Feb; 112(4):800-5. PubMed ID: 18172902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014.
    Tabakin AL; Shinder BM; Kim S; Rivera-Nunez Z; Polotti CF; Modi PK; Sterling JA; Farber NJ; Radadia KD; Parikh RR; Kim IY; Saraiya B; Mayer TM; Singer EA; Jang TL
    Clin Genitourin Cancer; 2020 Apr; 18(2):e194-e201. PubMed ID: 31818649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.